Lonza is a global leader in contract development and manufacturing services with strong R&D capabilities and world-class facilities across five continents. In 2020, Lonza supported more than 820 pre-clinical and clinical small and large molecules, more than 245 commercial small and large molecules and produced 230 billion capsules.

Award
  • Nominated in 2020

  • Winner in 2021